XML 34 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1

Proposed Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. (Tables)

6 Months Ended

Jan. 31, 2018

Spin-Off of Rafael Holdings, Inc. and Investment in Rafael Pharmaceuticals, Inc. [Abstract]

Schedule of consolidated balance sheets

		January 31, 2018				July 31, 2017
		(in thousands)
Series D Note (at fair value)		$	6,300			$	6,300
Warrants (at cost)			5,400				5,400
Right to receive additional shares (at cost)			—				400
Total investment in Rafael Pharma		$	11,700			$	12,100

X

- Definition

Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.

+ References

No definition available.

+ Details

Name:	us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfInvestmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration